Standing Order
Legend Biotech Corporation

Dashboard

Legend Biotech Corporation

LEGNNASDAQ

For informational purposes only. Not financial advice, not a recommendation to buy or sell any security. Standing Order is a directory and research project, not an advisory service.

Universal block

Live market data + trailing fundamentals.

Market cap$3.6B
Price$18.4552w $16.65 – $44.32
Conviction3/ 5
Revenue (TTM)$1.3B
Revenue growth YoY+59.5%
P/E (trailing)—
Gross margin56.6%
Operating margin-4.4%
Net margin-7.2%
52w price change-37.1%
Next earningsNov 11, 2026

Recent events

Material filings, federal awards, and regulatory activity. Impact is scored against market cap.

  • Sep 23
    Ownership changeSEC

    Form 4 insider transaction filing.

  • Sep 16
    Ownership changeSEC

    Form 4 insider transaction filing dated 2026-09-16.

  • Sep 15
    OtherSEC

    Legend Biotech files Form 6-K foreign issuer report.

  • Sep 14
    OtherSEC

    Legend Biotech Corporation files Form 6-K with the SEC.

  • Aug 18
    OtherSEC

    Legend Biotech files Form 6-K foreign issuer report.

  • Aug 18
    Ownership changeSEC

    Form 4 insider transaction filing

  • Aug 11
    Financial resultsSEC

    Legend Biotech files 6-K containing interim report for period ended June 30, 2026.

  • Aug 6
    OtherSEC

    Legend Biotech filed Form 6-K with the SEC on 2026-08-06.

  • Jul 27
    OtherSEC

    Legend Biotech files Form 6-K with the SEC on 2026-07-27.

  • Jul 15
    OtherSEC

    Legend Biotech filed Form 6-K with SEC on 2026-07-15 (items unspecified).

  • Jul 2
    Ownership changeSEC

    Form 4 insider transaction filing for LEGN

  • Jul 2
    Ownership changeSEC

    SEC Form 4 insider transaction filing

  • Jun 29
    Ownership changeSEC

    SEC Form 4 insider transaction filing.

  • Jun 22
    OtherSEC

    Legend Biotech filed Form 6-K as foreign private issuer report.

  • Jun 18
    Securities offeringSEC

    Filed SEC Form 424B5 prospectus supplement.

  • Jun 17
    Securities offeringSEC

    Filed 424B5 prospectus supplement related to securities offering.

  • Jun 15
    OtherSEC

    Legend Biotech filed Form 6-K with the SEC.

  • Jun 2
    OtherSEC

    Legend Biotech filed Form 6-K with the SEC on 2026-06-02.

  • Jun 1
    OtherSEC

    Legend Biotech Corporation filed Form 6-K with the SEC.

  • May 21
    OtherSEC

    Legend Biotech filed Form 6-K foreign issuer report.

Not financial advice — research and opinion only. Disclosures